Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia.. Daily Stock Analysis

Daily Stock Analysis, GASX, Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia., priceseries

Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia.. Daily Stock Analysis
Stock Information
Open
14.71
Close
16.00
High
16.00
Low
14.42
Previous Close
13.37
Daily Price Gain
2.63
YTD High
62.73
YTD High Date
Jan 20, 2016
YTD Low
1.47
YTD Low Date
Jul 10, 2018
YTD Price Change
-0.10
YTD Gain
-0.63%
52 Week High
62.73
52 Week High Date
Jan 20, 2016
52 Week Low
1.47
52 Week Low Date
Jul 10, 2018
52 Week Price Change
-0.10
52 Week Gain
-0.63%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 24. 2017
3.09
Jun 12. 2017
3.67
12 Trading Days
18.60%
Link
LONG
Jun 14. 2017
3.82
Jun 23. 2017
4.18
7 Trading Days
9.48%
Link
LONG
Aug 2. 2017
3.65
Aug 23. 2017
4.19
15 Trading Days
14.72%
Link
LONG
Jan 29. 2018
2.02
Feb 15. 2018
2.84
13 Trading Days
40.74%
Link
LONG
Aug 7. 2018
1.76
Aug 21. 2018
1.89
10 Trading Days
7.58%
Link
LONG
Oct 17. 2018
1.87
Nov 1. 2018
2.53
11 Trading Days
35.16%
Link
LONG
Nov 12. 2018
2.68
Dec 3. 2018
2.99
14 Trading Days
11.53%
Link
LONG
Dec 4. 2018
3.15
Dec 26. 2018
5.16
14 Trading Days
63.53%
Link
LONG
Feb 5. 2019
3.23
Feb 13. 2019
3.42
6 Trading Days
5.86%
Link
LONG
Apr 25. 2019
2.75
May 10. 2019
3.17
11 Trading Days
15.54%
Link
LONG
May 22. 2019
3.51
Jun 18. 2019
4.70
18 Trading Days
34.17%
Link
LONG
Jul 15. 2019
4.80
Jul 30. 2019
5.54
11 Trading Days
15.34%
Link
LONG
Aug 1. 2019
6.44
Aug 19. 2019
7.61
12 Trading Days
18.22%
Link
LONG
Sep 24. 2019
5.32
Oct 23. 2019
7.64
21 Trading Days
43.74%
Link
LONG
Jan 16. 2020
4.53
Feb 5. 2020
7.05
13 Trading Days
55.58%
Link
LONG
Feb 21. 2020
8.43
Mar 13. 2020
25.06
15 Trading Days
197.40%
Link
Company Information
Stock Symbol
GASX
Exchange
NASDAQ
Company URL
http://www.galectintherapeutics.com
Company Phone
678-620-3186
CEO
Peter G. Traber
Headquarters
Georgia
Business Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA 30071
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001133416
About

Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA.

Description

Galectin Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic disease and cancer. The company's lead product candidate includes galectin-3 inhibitor (GR-MD-02), a galactoarabino-rhamnogalacturonan polysaccharide polymer for the treatment of liver fibrosis and liver cirrhosis in non-alcoholic steatohepatitis patients, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development state for the treatment of cardiac and vascular fibrosis, as well as focuses on developing GR-MD-02 for the treatment of psoriasis. The company, through its collaborative joint venture, Galectin Sciences, LLC with SBH Sciences, Inc., is also involved in the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading